Why Is PULSE BIOSCIENCES IN (PLSE) Stock Up Today?

Why PLSE stock is up today

Pulse Biosciences stock surged 11.67% to $33.79 on Tuesday as the company announced it will host a conference call to discuss its second quarter 2026 financial results on August 6, 2026. The call is scheduled for 1:30 p.m. PT after the market close, with a live and recorded webcast available on its investor website. The move follows recent insider purchases and a positive earnings report.

What Happened

The CEO and a director of Pulse Biosciences purchased approximately $13.3 million in shares via an ATM program on May 11, 2026. These insider transactions occurred alongside the company's Q1 earnings report, which showed an EPS of $(0.27), beating the $(0.32) estimate, and revenue of $401,000, exceeding the $400,000 estimate. Canaccord Genuity initiated coverage on Pulse Biosciences with a Buy rating and a price target of $32. The company also announced that earnings are scheduled for May 4, 2026.

What The Data Shows

Intraday, the stock opened at $30.43 with a 0.6% gap up from the previous close of $30.26. The session high reached $33.87 at 2:05 PM ET, while the low was $29.71 at 9:55 AM ET. Trading volume stood at 0.2 million shares, which is 0.6 times the 3-month daily average. The stock closed the session at $33.72, up from its opening price. Pulse Biosciences has a market cap of $2.0 billion and an unprofitable track record with an EPS TTM of -1.10. The stock's 52-week range is $12.56 to $31.00.

What To Watch

Investors should monitor the company's earnings report scheduled for May 4, 2026, as well as the upcoming conference call on August 6, 2026, for further business updates.